Bright Minds Biosciences Inc. (DRUG) PT Raised to $220 at Piper Sandler

May 20, 2026 6:52 AM

Piper Sandler analyst Yasmeen Rahimi raised the price target on Bright Minds Biosciences Inc. (NASDAQ: DRUG) to $220.00 (from $190.00) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found